InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: wetcement post# 1223

Monday, 02/10/2014 4:29:47 PM

Monday, February 10, 2014 4:29:47 PM

Post# of 5006
RXI-109

1. Started a phase 2a trial for hypertrophic scars November 15th 2013, and it is expected to last at least 1 year.

2. RXI-109 for Keloid removal is set to start Q1 2014 so at least before March 2014.

3. RXI-109 for breast surgery scars is set to start late Q2/ early Q3 2014 phase 2a.

All trials are expected to release initial scar reduction results 3 months after trial starts. So it is possible by late feb/early march we will see some initial data for the phase 2a hypertrophic scar study.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PHIO News